| Announce Date | 02/02/2026 |
| EPS Normalized Actual | $0.97 (Miss by $-0.04) |
| EPS GAAP Actual | $0.97 (Miss by $-0.04) |
| Revenue Actual | $14.313B |
| Revenue Surprise | Beat by $14313M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2028 | 6.86 | 9.23 | 6.80482 | 6.9123 | 2 |
| Sep 2028 | 6.0712 | 10.43 | 6.00468 | 6.23648 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.25 | 0.25 | 14.313B | 4.82% | 14313M |
| FQ3 2025 (Sep 2025) | 0.12 | 0.12 | 13.86B | 2.13% | 13860M |
| FQ2 2025 (Jun 2025) | 0.18 | 0.18 | 13.884B | 3.82% | 13884M |
| FQ1 2025 (Mar 2025) | 0.02 | 0.02 | 13.074B | -93.35% | 13074M |
| FQ4 2024 (Dec 2024) | 1.04 | 1.04 | 13.623B | 100% | 13623M |
| FQ3 2024 (Sep 2024) | 1.03 | 1.03 | 13.565B | -88.74% | 13565M |
| FQ2 2024 (Jun 2024) | 0.55 | 0.55 | 13.353B | 1.65% | 13353M |
| FQ1 2024 (Mar 2024) | 0.37 | 0.37 | 25.278B | 100% | 25278M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 1.37119 | -- | 1.33232 | 1.40226 | 2 |
| FQ1 2028 (Mar 2028) | 1.30701 | -- | 1.26996 | 1.33662 | 2 |
| FQ4 2027 (Dec 2027) | 1.17769 | -- | 1.1443 | 1.20437 | 1 |
| FQ3 2027 (Sep 2027) | 1.22393 | -- | 1.21288 | 1.24906 | 2 |
| FQ2 2027 (Jun 2027) | 1.23528 | -- | 1.22412 | 1.26064 | 2 |
| FQ1 2027 (Mar 2027) | 1.23044 | -- | 1.21933 | 1.2557 | 2 |
| FQ4 2026 (Dec 2026) | 1.37082 | 81.76 | 1.35844 | 1.39896 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 14.53B | -- | 14.21B | 14.78B | 1 |
| FQ1 2028 (Mar 2028) | 13.31B | -- | 13.02B | 13.54B | 1 |
| FQ4 2027 (Dec 2027) | 13.87B | -- | 13.57B | 14.11B | 2 |
| FQ3 2027 (Sep 2027) | 14.24B | -- | 14.14B | 14.46B | 3 |
| FQ2 2027 (Jun 2027) | 13.93B | -- | 13.84B | 14.15B | 3 |
| FQ1 2027 (Mar 2027) | 13.35B | -- | 13.26B | 13.56B | 3 |
| FQ4 2026 (Dec 2026) | 13.65B | -4.83 | 13.56B | 13.87B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.25 | 0.25 | 100% | |
| FQ3 2025 (Sep 2025) | 0.12 | 0.12 | 100% | |
| FQ2 2025 (Jun 2025) | 0.18 | 0.18 | 100% | |
| FQ1 2025 (Mar 2025) | 0.02 | 0.02 | 100% | |
| FQ4 2024 (Dec 2024) | 1.04 | 1.04 | 100% | |
| FQ3 2024 (Sep 2024) | 1.03 | 1.03 | 100% | |
| FQ2 2024 (Jun 2024) | 0.55 | 0.55 | 100% | |
| FQ1 2024 (Mar 2024) | 0.37 | 0.37 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $14.31B | $14313M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $13.86B | $13860M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $13.88B | $13884M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $13.07B | $13074M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $13.62B | $13623M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $13.57B | $13565M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $13.35B | $13353M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $25.28B | $25278M | 100% |